Literature DB >> 24445837

Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.

Felice C Adler-Shohet1, Julie Low, Michael Carson, Haimanot Girma, Jasjit Singh.   

Abstract

After exposure to a teacher with multidrug-resistant pulmonary tuberculosis, 31 children developed latent infection. Twenty-six were treated with levofloxacin and pyrazinamide. Twelve required a change in therapy secondary to adverse effects. The most common adverse effects included abdominal pain, arthralgias/myalgias and elevated transaminases. All children reported at least 1 adverse effect. Fifteen children completed treatment. All adverse effects were transient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24445837     DOI: 10.1097/INF.0000000000000260

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  12 in total

1.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

2.  Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.

Authors:  Nishi Suryavanshi; Matthew Murrill; Amita Gupta; Michael Hughes; Anneke Hesseling; Soyeon Kim; Linda Naini; Lynne Jones; Betsy Smith; Nikhil Gupte; Rodney Dawson; Vidya Mave; Sushant Meshram; Alberto Mendoza-Ticona; Jorge Sanchez; Nagalingeswaran Kumarasamy; Kyla Comins; Francesca Conradie; Justin Shenje; Sandy Nerette Fontain; Anthony Garcia-Prats; Aida Asmelash; Supalert Nedsuwan; Lerato Mohapi; Umesh Lalloo; Ana Cristina Garcia Ferreira; Elisha Okeyo; Susan Swindells; Gavin Churchyard; N Sarita Shah
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 3.  Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.

Authors:  Suzanne M Marks; Sundari R Mase; Sapna Bamrah Morris
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

Review 4.  A scoping review of paediatric latent tuberculosis infection care cascades: initial steps are lacking.

Authors:  Jeffrey I Campbell; Thomas J Sandora; Jessica E Haberer
Journal:  BMJ Glob Health       Date:  2021-05

5.  Risk Factors for Adverse Events in Household Contacts Prescribed Preventive Treatment for Drug-resistant Tuberculosis Exposure.

Authors:  Amyn A Malik; Mercedes C Becerra; Timothy L Lash; Lisa M Cranmer; Saad B Omer; Junaid Fuad; Sara Siddiqui; Farhana Amanullah; Maria Jaswal; Naseem Salahuddin; Salmaan Keshavjee; Hamidah Hussain; Neel R Gandhi
Journal:  Clin Infect Dis       Date:  2021-05-18       Impact factor: 20.999

6.  Moxifloxacin Prophylaxis against MDR TB, New York, New York, USA.

Authors:  Lisa Trieu; Douglas C Proops; Shama D Ahuja
Journal:  Emerg Infect Dis       Date:  2015-03       Impact factor: 6.883

Review 7.  Is Chemoprophylaxis for Child Contacts of Drug-Resistant TB Patients Beneficial? A Systematic Review.

Authors:  C Padmapriyadarsini; Mrinalini Das; Sharath Burugina Nagaraja; Mahalakshmi Rajendran; Richard Kirubakaran; Sarabjit Chadha; Prathap Tharyan
Journal:  Tuberc Res Treat       Date:  2018-04-02

8.  An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP+.

Authors:  Liesbeth F Mieras; Anna T Taal; Wim H van Brakel; Emmanuelle Cambau; Paul R Saunderson; W Cairns S Smith; Cita Rosita S Prakoeswa; Linda Astari; David M Scollard; Dejair Caitano do Nascimento; Jacques Grosset; Hemanta K Kar; Shinzo Izumi; Laura Gillini; Marcos C L Virmond; Marieke G G Sturkenboom
Journal:  BMC Infect Dis       Date:  2018-10-05       Impact factor: 3.090

9.  Tuberculosis among Full-Time Teachers in Southeast China, 2005⁻2016.

Authors:  Hongdan Bao; Kui Liu; Zikang Wu; Chengliang Chai; Tieniu He; Wei Wang; Fei Wang; Ying Peng; Xiaomeng Wang; Bin Chen; Jianmin Jiang
Journal:  Int J Environ Res Public Health       Date:  2018-09-17       Impact factor: 3.390

Review 10.  Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda.

Authors:  Carole D Mitnick; Carly A Rodriguez; Marita L Hatton; Grania Brigden; Frank Cobelens; Martin P Grobusch; Robert Horsburgh; Christoph Lange; Christian Lienhardt; Eyal Oren; Laura J Podewils; Barbara Seaworth; Susan van den Hof; Charles L Daley; Agnes C Gebhard; Fraser Wares
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.